Any current/future capex/capital investment/strategic investment?

Recent CapEx was incurred to increase bed capacity from 130 to 330 beds, primarily through strategic acquisitions and leases rather than owning properties, minimizing capital outlay. No plans to invest in building ownership going forward; existing newly acquired hospitals are on rental/lease agreements. Planned CapEx of around ₹4-5 Cr over the next year for setting up 2 IVF centers, including equipment and operational costs. IVF centers expected to start before March 2024; potential for partnership or takeover of existing centers. Expansion plan includes increasing capacity to 430 beds and gro

Future growth expectations in sales/revenue/volumes?

Target revenue for current year (FY 23-24): Around Rs. 28 to 32 crore, depending on PMJAY strategy. Projected revenue in 2-3 years (FY 25-26): Around Rs. 80 to 90 crore. Expected revenue for next year: Approximately Rs. 45 to 50 crore. Growth driven by strategic acquisitions of multi-specialty hospitals and expansion into new verticals like IVF centers. Expansion plan includes increasing bed capacity from current 330 beds to 430 beds. Geographic expansion planned in four states: Gujarat, Madhya Pradesh, Rajasthan, and Maharashtra by 2027. Focus on high-margin services such as IVF centers start

Future growth expectations in earnings/operating earnings/profits/EPS?

Projected turnover for current year: around Rs. 30 crore Expected turnover in 2-3 years: Rs. 80 to 90 crore Anticipated turnover next year (approximate): Rs. 45 to 50 crore Net profit margin expected to be around 20% as turnover scales up EBITDA margin currently strong at 46.7% with PAT margin at 25.9% in H1 FY '24 Future growth driven by strategic acquisitions, bed capacity expansion (from 330 to 430 beds), and new verticals like IVF centers IVF centers anticipated to start before March 2024, expected to generate high revenue and profit Operating margin expected to be maintained

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention the current or expected order book or pending orders. The focus is primarily on hospital acquisitions, expansions, and revenue projections rather than specific order books. The company has recently expanded bed capacity from 130 to 330 beds, aiming for 430 beds. Future growth strategies include expanding in states like Rajasthan, Madhya Pradesh, Gujarat, Maharashtra, and launching IVF centers. Revenue projections for the next 2-3 years are around Rs. 80-90 crores, with a 20% net profit margin aimed. No direct reference to an order book or pending orde

Aatmaj Healthcare LtdQ2 FY24Healthcare Services

Aatmaj Healthcare Ltd Q2 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹23.8P/E: 74.7Market Cap: ₹54 CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2

Target revenue for current year (FY 23-24): Around Rs. 28 to 32 crore, depending on PMJAY strategy.
Projected revenue in 2-3 years (FY 25-26): Around Rs. 80 to 90 crore.
Expected revenue for next year: Approximately Rs. 45 to 50 crore.
Growth driven by strategic acquisitions of multi-specialty hospitals and expansion into new verticals like IVF centers.
Expansion plan includes increasing bed capacity from current 330 beds to 430 beds.
Geographic expansion planned in four states: Gujarat, Madhya Pradesh, Rajasthan, and Maharashtra by 2027.
Focus on high-margin services such as IVF centers starting before the end of the current financial year.
Emphasis on maintaining 20% net profit margin as turnover increases, though margins may vary with scale.

Margin guidance

Category 3

Projected turnover for current year: around Rs. 30 crore
Expected turnover in 2-3 years: Rs. 80 to 90 crore
Anticipated turnover next year (approximate): Rs. 45 to 50 crore
Net profit margin expected to be around 20% as turnover scales up
EBITDA margin currently strong at 46.7% with PAT margin at 25.9% in H1 FY '24
Future growth driven by strategic acquisitions, bed capacity expansion (from 330 to 430 beds), and new verticals like IVF centers
IVF centers anticipated to start before March 2024, expected to generate high revenue and profit
Operating margin expected to be maintained in future due to focused business model and cost control
Expansion planned in four states (Gujarat, Madhya Pradesh, Rajasthan, Maharashtra) over next 2-3 years
No immediate plans for further fund raising; focus on efficient management and organic growth

See what Aatmaj Healthcare Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

- Currently, there is no immediate plan to raise further funds through debt or equity. - The Managing Director, Dr. Tushar Suvagiya, stated that he has not thought about raising further funds at present. - Future capital expenditure, such as for IVF centers and potential onco-radiation units, will require significant investment (around Rs. 4-5 crores for IVF centers alone). - The company is focusing on growth through strategic acquisitions and partnerships rather than immediate fundraising. - Any decision on future fundraising will depend on business expansion needs and capital requirements, especially for high-cost ventures like onco-radiation therapy. (Reference: Page 7 and Page 5-6 excerpts from the transcript)

Order book

The transcript does not explicitly mention the current or expected order book or pending orders.
The focus is primarily on hospital acquisitions, expansions, and revenue projections rather than specific order books.
The company has recently expanded bed capacity from 130 to 330 beds, aiming for 430 beds.
Future growth strategies include expanding in states like Rajasthan, Madhya Pradesh, Gujarat, Maharashtra, and launching IVF centers.
Revenue projections for the next 2-3 years are around Rs. 80-90 crores, with a 20% net profit margin aimed.
No direct reference to an order book or pending orders is provided in the available transcript content.

See what Aatmaj Healthcare Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Recent CapEx was incurred to increase bed capacity from 130 to 330 beds, primarily through strategic acquisitions and leases rather than owning properties, minimizing capital outlay.
No plans to invest in building ownership going forward; existing newly acquired hospitals are on rental/lease agreements.
Planned CapEx of around ₹4-5 Cr over the next year for setting up 2 IVF centers, including equipment and operational costs.
IVF centers expected to start before March 2024; potential for partnership or takeover of existing centers.
Expansion plan includes increasing capacity to 430 beds and growing presence in Gujarat, Rajasthan, Madhya Pradesh, and Maharashtra.
High-capital projects like oncology radiation therapy (costing ~₹16 Cr) are currently on hold due to financial prudence.
No immediate plans for further fund raising for capital investments; focus is on organic growth and acquisitions.

Track Aatmaj Healthcare Ltd — get its next earnings analysis in your feed

How does Aatmaj Healthcare Ltd rank vs peers in Healthcare Services?

Pro feature

ThisAatmaj Healthcare Ltd

Rev 2Mar 3

See where Aatmaj Healthcare Ltd sits in Healthcare ServicesSee which companies these are, and every other name in the sector.Open rankings

How does Aatmaj Healthcare Ltd rank in Healthcare Services?

Compare Aatmaj Healthcare Ltd against every Healthcare Services company (Q2 FY24) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

What Aatmaj Healthcare Ltd's management said in earlier quarters

Others in Healthcare Services this season

Rainbow Childrens Medicare Ltd (Q2 FY27)
Year-on-year (YoY) growth in revenue: 23.2% . Key investor presentation takeaways from Rainbow Childrens Medicare Ltd's Q2 FY27 investor presentation — and how
Narayana Hrudayalaya Ltd (Q2 FY27)
Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27
Artemis Medicare Services Ltd (Q2 FY27)
Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Key investor presentation takeaways from Artemis Medicare Service
Max Healthcare Institute Ltd (Q2 FY27)
Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) . Key investor presentation takeaways from Max Healthcare Institute Ltd's Q2 FY27 investor presentatio

Compare:vs Apollo Hospitals Enterprise Ltd vs Manipal Health Enterprises Ltd vs Max Healthcare Institute Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →